Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice

Nature Medicine
J TianD L Kaufman

Abstract

In nonobese diabetic (NOD) mice, beta-cell reactive T-helper type 1 (Th1) responses develop spontaneously and gradually spread, creating a cascade of responses that ultimately destroys the beta-cells. The diversity of the autoreactive T-cell repertoire creates a major obstacle to the development of therapeutics. We show that even in the presence of established Th1 responses, it is possible to induce autoantigen-specific anti-inflammatory Th2 responses. Immune deviation of T-cell responses to the beta-cell autoantigen glutamate decarboxylase (GAD65), induced an active form of self-tolerance that was associated with an inhibition of disease progression in prediabetic mice and prolonged survival of syngeneic islet grafts in diabetic NOD mice. Thus, modulation of autoantigen-specific Th1/Th2 balances may provide a minimally invasive means of downregulating established pathogenic autoimmune responses.

References

Aug 21, 1992·Science·F Ramsdell, B J Fowlkes
Jan 1, 1990·Annual Review of Immunology·S S Zamvil, L Steinman
Jan 1, 1990·Annual Review of Immunology·L Castaño, G S Eisenbarth
Mar 19, 1994·Lancet·D Elias, I R Cohen
Aug 1, 1994·Endocrine Reviews·J F Bach
Oct 19, 1993·Biochimica Et Biophysica Acta·D S LeeD L Kaufman
Jan 18, 1994·Proceedings of the National Academy of Sciences of the United States of America·R Tisch, H O McDevitt
Jan 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·D Daniel, D R Wegmann
Mar 22, 1996·Science·T ForsthuberP V Lehmann

❮ Previous
Next ❯

Citations

Mar 30, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Roberto Mallone, Gerald T Nepom
Apr 8, 1999·Chirurgie; mémoires de l'Académie de chirurgie·F TriponezP Morel
Jan 13, 1998·Immunology Today·R LiblauH O McDevitt
Apr 30, 1999·Diabetes Research and Clinical Practice·W Y NgJ S Cheah
Mar 21, 2000·Diabetes Research and Clinical Practice·H Y SongR C McEvoy
May 20, 2003·Journal of Autoimmunity·Gerald T Nepom
May 20, 2003·Journal of Autoimmunity·Hui-Yu QinBhagirath Singh
Jun 1, 1997·Research in Immunology·I BergerotT L Delovitch
Jan 13, 2000·Current Opinion in Immunology·F S Wong, C A Janeway
Aug 26, 1999·The Journal of Peptide Research : Official Journal of the American Peptide Society·L BerezhkovskiyS Deshpande
Jun 19, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Khaja K RehmanPaul D Robbins
Aug 20, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Damien BressonMatthias von Herrath
Aug 26, 2006·Nature Clinical Practice. Endocrinology & Metabolism·Simona Cernea, Kevan C Herold
Aug 30, 2001·Nature Immunology·A CookeN M Parish
Dec 1, 1996·Nature Medicine·M Solimena, P De Camilli
May 26, 1999·Clinical and Experimental Immunology·A Hartemann-HeurtierC Boitard
Mar 17, 2001·Diabetic Medicine : a Journal of the British Diabetic Association·S A WhiteM L Nicholson
Oct 10, 2008·The New England Journal of Medicine·Denise L Faustman
Oct 10, 2008·The New England Journal of Medicine·Johnny LudvigssonRosaura Casas
Jun 11, 2003·The Journal of Experimental Medicine·Elmar JaeckelHarald von Boehmer
Jan 19, 2002·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·S A BrodW J Riley
Jan 5, 2002·Diabetes Technology & Therapeutics·K Lin-SuN K Maclaren
Oct 31, 1998·Immunological Reviews·J TianD L Kaufman
Mar 13, 2001·Annual Review of Immunology·J F Bach, L Chatenoud
Jul 26, 2011·Clinical & Developmental Immunology·Brett PhillipsNick Giannoukakis
Feb 14, 1998·The Journal of Clinical Investigation·D ZekzerR S Sherwin
May 6, 2014·Disease Models & Mechanisms·Dawn E SmilekGerald T Nepom
Jul 24, 2001·Clinical Immunology : the Official Journal of the Clinical Immunology Society·I Urbanek-RuizC G Fathman
Aug 2, 2002·Journal of Endocrinological Investigation·M I Hawa, R D G Leslie
Feb 7, 2014·Annual Review of Immunology·Emil R Unanue
Dec 13, 2005·Proceedings of the National Academy of Sciences of the United States of America·Gabrielle G M PinkseBart O Roep
Dec 6, 2000·Proceedings of the National Academy of Sciences of the United States of America·C P LiuW J Lin
Jul 22, 1997·Proceedings of the National Academy of Sciences of the United States of America·S D PatelG Sonderstrup-McDevitt
Aug 4, 1999·Proceedings of the National Academy of Sciences of the United States of America·C C ChaoH O McDevitt
Aug 26, 1998·Proceedings of the National Academy of Sciences of the United States of America·L GengA C Hayday
Apr 12, 2007·Current Diabetes Reports·Georgia FousteriDamien Bresson
Sep 7, 2001·Current Opinion in Immunology·J F Bach

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.